Trial intelligence / Profile preview

Goserelin for medical treatment of uterine fibroids

RBR-3r88x9Phase 4Completed

Sponsor
Financiamento próprio
Start
Oct 2015
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of goserelin in Fibromyoma (LM), sponsored by Financiamento próprio. Started Oct 2015; status: completed.

02

Drugs

goserelin
03

Conditions

Fibromyoma (LM)

Beyond the preview

Go deeper on RBR-3r88x9.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-3r88x9.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call